지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2008.10
- 수록면
- 235 - 239 (5page)
이용수
초록· 키워드
오류제보하기
Purpose: After the first subcutaneous mastectomy with nipple preservation in 1974 at the Nottingham Breast Clinic in United Kingdom, many studies have shown that skin-sparing mastectomy (SSM) with the preservation of the nipple-areola complex (NAC) is an oncologically safe procedure with good cosmetic outcomes in selected mastectomy patients. However, the clinical indications for NAC preservation have not yet been precisely defined. This study was performed to investigate the predictive factors for NAC-based neoplastic involvement to determine the indications for NAC preservation.
Methods: A retrospective study of 198 patients with invasive breast cancer who underwent modified radical mastectomy (MRM) at the Department of Surgery at Chonnam University Hospital from April of 2004 to April of 2006 was performed. Patients with bilateral breast cancer were excluded from the study. The predictive factors analyzed for NAC involvement were the hormone receptor status, tumor size, tumor localization, multiplicity, axillary lymph node status, nuclear grade, tumor-nipple distance (TND), and lymphovascular invasion (LVI).
Results: The overall frequency of malignant NAC involvement was 19 out of the 198 patients (9.5%) as determined by definitive histology. Significant differences were found for tumor size (P=0.015), axillary lymph node status (P=0.008), TND (P=0.044), and LVI (P=0.014). There were no significant differences for the hormone receptor status, multiplicity, nuclear grade, and localization.
Conclusion: Although the sample size in this study was small, the findings suggest that the clinical contraindications for NAC preservation should include tumors ＞2.4 cm, a positive axillary lymph node status, TND ＜4 cm, and positive LVI. NAC preservation can be offered in selected patients after preoperative or intraoperative evaluation of the tumor size, axillary node status, TND, and LVI.
Methods: A retrospective study of 198 patients with invasive breast cancer who underwent modified radical mastectomy (MRM) at the Department of Surgery at Chonnam University Hospital from April of 2004 to April of 2006 was performed. Patients with bilateral breast cancer were excluded from the study. The predictive factors analyzed for NAC involvement were the hormone receptor status, tumor size, tumor localization, multiplicity, axillary lymph node status, nuclear grade, tumor-nipple distance (TND), and lymphovascular invasion (LVI).
Results: The overall frequency of malignant NAC involvement was 19 out of the 198 patients (9.5%) as determined by definitive histology. Significant differences were found for tumor size (P=0.015), axillary lymph node status (P=0.008), TND (P=0.044), and LVI (P=0.014). There were no significant differences for the hormone receptor status, multiplicity, nuclear grade, and localization.
Conclusion: Although the sample size in this study was small, the findings suggest that the clinical contraindications for NAC preservation should include tumors ＞2.4 cm, a positive axillary lymph node status, TND ＜4 cm, and positive LVI. NAC preservation can be offered in selected patients after preoperative or intraoperative evaluation of the tumor size, axillary node status, TND, and LVI.
목차
서론
방법
결과
고찰
결론
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Predictive Role of Tumor Size in Breast Cancer with Axillary Lymph Node Involvement - Can Size of Primary Tumor be used to Omit an Unnecessary Axillary Lymph Node Dissection?
Asian Pacific journal of cancer prevention : APJCP
2013 .01
-
유방암 수술 환자에서 액와임파절 전이 Level(Level of Axillary Lymph Node)의 의의
Annals of Surgical Treatment and Research
1992 .06
-
Which Clinicopathological Factors Are Related to Tumor Size in Papillary Thyroid Cancer?
The Journal of Endocrine Surgery
2019 .01
-
10개 이상의 액와임파절 전이를 가진 유방암 환자에 대한 임상적 고찰
Annals of Surgical Treatment and Research
2000 .10
-
유방암에서 액와림프절 전이의 예측 인자
Annals of Surgical Treatment and Research
1999 .12
-
유방암의 액와림프절 전이에 대한 관련인자
Annals of Surgical Treatment and Research
1992 .12
-
Clinicopathological Significance of Lymphangiogenesis and Tumor Lymphovascular Invasion in Indonesian Breast Cancers
Asian Pacific journal of cancer prevention : APJCP
2013 .01
-
1 ㎝ 이하의 침윤성 유방암 환자에서 겨드랑이 림프절 전이에 대한 예측인자
Annals of Surgical Treatment and Research
2011 .01
-
T1 침윤성 유관암에서 액와부 림프절 전이에 영향을 주는 인자들
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2010 .12
-
Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer
Annals of Surgical Treatment and Research
2019 .04
-
림프절 전이가 없는 유방암의 임상적 고찰
Annals of Surgical Treatment and Research
2000 .05
-
Lymph node ratio as a prognostic factor for pathologic N3a breast cancer patients with 10 or more metastatic axillary lymph nodes
대한외과학회 학술대회 초록집
2017 .11
-
유방 촬영술시 보이는 액와부 림프절의 임상적 의의
Annals of Surgical Treatment and Research
1999 .11
-
T1 유방암 환자에서 액와림프절 전이의 예측인자
Annals of Surgical Treatment and Research
2000 .11
-
액와 림프절 전이가 없는 유방암에서 전신 재발에 영향을 미치는 인자들
Annals of Surgical Treatment and Research
2009 .10
-
The Relationship between Tumor-free Axillary Lymph Node Morphology and Clinicopathologic Features in Invasive Breast Cancer
대한임상종양학회 학술대회지
2015 .02
-
감시림프절 절제술만을 시행한 유방암 환자의 단기 추적 관찰 성적
Annals of Surgical Treatment and Research
2007 .10
-
조기유방암에서 유방보존술 후 재발에 영향을 주는 인자
Radiation oncology journal : ROJ
1997 .01
-
유방암 수술에 있어서 내시경을 이용한 액와림프절 절제술
Annals of Surgical Treatment and Research
1998 .06
-
10개 이상 액와 림프절 전이를 보인 유방암 환자의 예후
Annals of Surgical Treatment and Research
2008 .10
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2013-514-002689650